98 related articles for article (PubMed ID: 16184836)
21. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet's disease and association with HLA-B51 expression.
Sakly K; Lahmar R; Nefzi F; Hammami S; Harzallah O; Sakly N; Sakly W; Hassine M; Mahjoub S; Ghedira I; Feki S
Immunol Invest; 2014; 43(5):463-78. PubMed ID: 24661088
[TBL] [Abstract][Full Text] [Related]
23. HLA-B51 subtypes in Turkish patients with Behçet's disease and their correlation with clinical manifestations.
Demirseren DD; Ceylan GG; Akoglu G; Emre S; Erten S; Arman A; Metin A
Genet Mol Res; 2014 Jul; 13(3):4788-96. PubMed ID: 25062414
[TBL] [Abstract][Full Text] [Related]
24. Familial Behçet's disease.
Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
[TBL] [Abstract][Full Text] [Related]
25. Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis.
Calich AL; Viana VS; Cancado E; Tustumi F; Terrabuio DR; Leon EP; Silva CA; Borba EF; Bonfa E
Liver Int; 2013 Jul; 33(6):909-13. PubMed ID: 23522300
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
[TBL] [Abstract][Full Text] [Related]
27. Cognitive functioning in Behçet's disease.
Cavaco S; da Silva AM; Pinto P; Coutinho E; Santos E; Bettencourt A; Pinto C; Gonçalves A; Silva S; Gomes F; Carvalho L; Pereira C; Martins B; Correia J; Vasconcelos C
Ann N Y Acad Sci; 2009 Sep; 1173():217-26. PubMed ID: 19758154
[TBL] [Abstract][Full Text] [Related]
28. Mevalonate kinase gene mutations and their clinical correlations in Behçet's disease.
Arslan Taş D; Erken E; Yildiz F; Dinkçi S; Sakalli H
Int J Rheum Dis; 2014 May; 17(4):435-43. PubMed ID: 24411001
[TBL] [Abstract][Full Text] [Related]
29. Plasma homocysteine level and uveitis in Behçet's disease.
Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behçet's disease.
Alpsoy E; Elpek GO; Yilmaz F; Ciftcioglu MA; Akman A; Uzun S; Karakuzu A
Dermatology; 2005; 210(1):31-5. PubMed ID: 15604542
[TBL] [Abstract][Full Text] [Related]
31. [Behcet's disease and associations with HLA-B5 antigen (a review of literature and the authors' findings)].
Goloeva RG; Alekberova ZS; Guseva IA; Krylov MIu
Ter Arkh; 2010; 82(5):45-9. PubMed ID: 20597270
[TBL] [Abstract][Full Text] [Related]
32. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
33. A weak association of HLA-B*2702 with Behçet's disease.
Gül A; Uyar FA; Inanç M; Ocal L; Barrett JH; Aral O; Koniçe M; Saruhan-Direskeneli G
Genes Immun; 2002 Sep; 3(6):368-72. PubMed ID: 12209364
[TBL] [Abstract][Full Text] [Related]
34. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
[TBL] [Abstract][Full Text] [Related]
35. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase I and II autoantibodies in Behçet's disease.
Mentese A; Alver A; Demir S; Sumer A; Ozer Yaman S; Karkucak M; Aydin Capkin A; Us Altay D; Turan I
Acta Reumatol Port; 2017; 42(1):26-31. PubMed ID: 28198796
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet's disease patients receiving immunomodulatory treatment.
Cheng L; Li Y; Wu Z; Li L; Liu C; Liu J; Dai J; Zheng W; Zhang F; Tang L; Yu X; Li Y
BMC Immunol; 2021 Feb; 22(1):16. PubMed ID: 33618671
[TBL] [Abstract][Full Text] [Related]
38. [The immunological aspects of Behçet's syndrome].
Fodor F; Chiriţă E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1989; 33(1):17-20. PubMed ID: 2527387
[TBL] [Abstract][Full Text] [Related]
39. The antiribosomal P antibodies really elicit autoimmune hepatitis?
Jearn LH; Kim TY
Liver Int; 2014 Jan; 34(1):165-6. PubMed ID: 24106992
[No Abstract] [Full Text] [Related]
40. Absence of autoantibodies against oral and vascular-related cell lines in the sera of patients with Behcet's disease.
Ataollahi M; Gharesi-Fard B; Aflaki E
Clin Lab; 2013; 59(11-12):1271-6. PubMed ID: 24409661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
